Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT04551898 · COMPLETED
Trial details
- NCT number
- NCT04551898
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2021-05-25
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.